Events, News

Posted on January 6, 2026
Starts CET

METRINO Academy Session #1 : “Inside out the reactor — Industrialization of nanomedicines”

METRINO Academy Session #1 event banner. Title: “Inside out the reactor” — The industrialization of nanomedicines. Date and time: Jan. 15, 2026, 3 PM (CET). Speakers: Anne-Sophie Larivière (Nanobiotix, Senior Vice President Operations) and Laëtitia Rio (Nanobiotix, Associate Director – Pharma products development & nanoparticles physicochemical characterizations). “Register now” with a QR code; “Free webinar.” METRINO logo at top right and EU/EURAMET partnership logos at the bottom.


From bench to clinic: how nanomedicines are really manufactured

Join a live METRINO Academy session with Nanobiotix to explore how an innovative SME approaches GMP manufacturing, scale-up, and quality-by-design in nanomedicines, with a strong focus on reproducibility, fit-for-purpose measurements, and real industrial decision-making (interactive Q&A included).

Register for free

Full description of this webinar

Want a real-world view of how an innovative SME industrializes nanomedicines for clinical development — and how quality, reproducibility and fit-for-purpose measurements influence manufacturing choices? Join this METRINO Academy session #1 for a practical discussion at the intersection of manufacturing and nanomedicine metrology / quality control.

Speakers (Nanobiotix)

  • Anne-Sophie Larivière (SVP Operations)
  • Laëtitia Rio (Associate Director – Pharmaceutical products development & Nanoparticles physicochemical characterizations)

Session focus

In industrial manufacturing of nanomedicines, robust analytical methods are key to characterize nano-objects, but mastering process parameters to ensure consistent product reproducibility is critical. In this session, we will cover the basis of GMP manufacturing and why it is important, the challenges in scaling up from bench to industrial production, the different stages of product development from research to commercial production and the quality by design approach. We hope this presentation will help uncover remaining unmet needs in the industrial development of nanomedicines.

Why attend

  1. Get an SME industry perspective on GMP fundamentals, scale-up challenges, and how quality-by-design guides development from research to commercial production.
  2. Understand how measurement choices and process control come together to support consistent reproducibility of nano-objects.
  3. Bring your questions: the session is designed to be interactive and to help surface unmet needs for the wider community.

Who is this for?

Open to both experts and non-experts, whether your background is primarily in metrology/analytical methods or in nanomedicine R&D/manufacturing/QA-QC/regulatory.

Format

1 hour (hands-on talk + live Q&A). Cameras welcome; microphones muted by default.

Join the METRINO academy Session #1!

******************

About the METRINO Academy

A short webinar series designed to translate METRINO outcomes into practical, user-oriented guidance for the broader community, with a focus on real-life decisions (quality control, reproducibility, standardisation readiness).

About Nanobiotix

Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based nanotherapeutics, with the ambition to improve outcomes for people with cancer and other challenging diseases. nanobiotix.com

Share this
Metrology for Innovative Nanotherapeutics
Get Social

The METRINO project has received funding from the European Partnership on Metrology (Grant #22HLT04), co-financed from the European Union’s Horizon Europe Research and Innovation Programme and by the Participating States. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or EURAMET. Neither the European Union nor the granting authority can be held responsible for them.

© 2026 — The METRINO Project